Clementia Pharmaceuticals (CMTA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CMTA Annual Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Clementia Pharmaceuticals.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2018)
(Sep 30 2018) (Jun 30 2018) (Mar 31 2018) (Dec 31 2017)
Assets
Cash And Cash Equivalents94.97
Cash & Short-term Investments94.00
Other Current Assets79.17
Total Current Assets174.14
Equipment/Property/Plant Net0.01
Intangible Assets1.66
Tax Assets, Noncurrent41.11
Other Assets, Noncurrent2.00
Total Assets176.84
Liabilities
Current Accounts Payable AndAccrued Liabilities12.41
Other Liabilities, Current0.00
Total Current Liabilities12.41
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Total Liabilities12.41
Stockholders' Equity
Other Equity164.43
Common Stockholder's Equity164.43
Total Stockholder's Equity164.43
Liabilities & Stockholder's Equity176.84
4 historic quarters locked

Sign in to unlock the full Clementia Pharmaceuticals balance sheet history.

About CMTA Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License